Tauriga Sciences Inc., of New York, said it received a comprehensive update from Immunovative Therapies Ltd. (ITL), of Shoham, Israel, including news that ITL plans to relaunch clinical trials in Thailand in metastatic cancer and in Israel in liver cancer later this month.